Equities

Panacea Life Sciences Holdings Inc

PLSH:PKL

Panacea Life Sciences Holdings Inc

Actions
  • Price (USD)0.1287
  • Today's Change0.00 / 0.00%
  • Shares traded275.00
  • 1 Year change-35.65%
  • Beta2.9938
Data delayed at least 15 minutes, as of Sep 17 2024 18:27 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Directors & dealings data is unavailable for this security.

Directors & Officers

Click or tap a row for biographies

NameTitleCompensationAgeOfficer since
Leslie ButtorffChairman of the Board, Chief Executive Officer--652021
Nick CavarraSenior Vice President - Marketing and Sales--582019
James BaumgartnerChief Science Officer and Quality Control--582017
Nathan BermanController--352021
Lawrence WertIndependent Director--662021
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.